Studies suggest that changes to protein consumption may alter glutathione production and contribute to a decrease in antioxidant capacity
Oral GLP-1 medications overcame this hurdle by pairing semaglutide with SNAC, an absorption-enhancing compound
You should expect: Regular weight and BMI measurements Periodic thyroid function tests (typically 68 weeks after starting GLP-1 therapy, after significant weight loss, and then every 612 months) Assessment of side effects and treatment tolerance Review of overall health status and comorbidities When to seek medical advice : Contact your GP promptly if you experience severe or persistent nausea and vomiting, signs of pancreatitis (severe abdominal pain), right upper abdominal pain with fever or jaundice (possible gallbladder disease), symptoms suggesting worsening thyroid function, or any concerning new symptoms
Dopaminergic pathways are similarly affected, with reduced tyrosine hydroxylase activity leading to diminished dopamine in the basal ganglia and prefrontal cortex, manifesting as anhedonia, reduced motivation, and psychomotor retardation (73, 74)
Activating the immune system , leading to inflammatory responses throughout the body